ZIC2 acts as a chromatin modifier to determine cell fate specification in stem cells and cancer. KU Leuven
In this project we will use neuro-ectodermal differentiation, a process where ZIC2 is clearly described to play a role in, and fresh CRC patient derived organoids to elucidate its mechanism of action in both a development and cancer setting using well established methods.